Ledger.Open graph →
SEC Form D · filed December 17, 2021

Glympse Bio, Inc

Offering
$18.0M
Sold
$18.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (35)

George Zachary · Cambridge, MADirectorCaroline Loew · Cambridge, MAExec · DirectorRobert Langer · Cambridge, MADirectorSteve Kafka · Cambridge, MADirectorStanley Lapidus · Cambridge, MADirectorFrancis Cuss · Cambridge, MADirectorTheresia Gouw · Cambridge, MADirectorAmy Schulman · Cambridge, MADirectorWendy W. Adamovich · Cambridge, MAExecStephen Carnes · Winter Park, FLDirectorMonika Mantilla · Coral Gables, FLDirectorJanice Price · LOS ANGELES, CAExec · DirectorJeff W. Wilson · Vancouver, British Columbia, CanadaDirectorStephen Fitzgerald · Concord, NHDirectorJohn Wenger · VANCOUVER, British Columbia, CanadaDirectorTero R. Kosonen · VANCOUVER, British Columbia, CanadaExecJordan Wan · Dover, DEDirectorJohn Wagner · LOS ANGELES, CADirectorTram W. Tran · Cambridge, MAExecJessica W. Atkinson · 35 Cambridgepark Dr., Suite 10, MAExecDhaval W. Gosalia · 35 Cambridgepark Dr., Suite 10, MAExecMatthew W. Navarro · Cambridge, MAExecTracy E. Watkins · WELLSBORO, PADirectorThomas L. Rudy, Jr · WELLSBORO, PADirectorClark S. Frame · WELLSBORO, PAExec · DirectorRobert G. Loughery · WELLSBORO, PADirectorShelley L. D'Haene · WELLSBORO, PADirectorAaron K. Singer · WELLSBORO, PADirectorSusan E. Hartley · WELLSBORO, PADirectorStephen M. Dorwart · WELLSBORO, PADirectorBlair T. Rush · WELLSBORO, PAExecTram W. Tran · Cambridge, MAExecJessica W. Atkinson · 35 Cambridgepark Dr., Suite 10, MAExecDhaval W. Gosalia · 35 Cambridgepark Dr., Suite 10, MAExecMatthew W. Navarro · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗